Quantum-Si Registers Class A Stock, Warrants on NASDAQ
Ticker: QSIAW · Form: 8-K · Filed: Feb 5, 2024 · CIK: 1816431
| Field | Detail |
|---|---|
| Company | Quantum-Si Inc (QSIAW) |
| Form Type | 8-K |
| Filed Date | Feb 5, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $11.50 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: compliance, exchange-listing, warrants
TL;DR
**Quantum-Si just confirmed its stock and warrants are properly listed on NASDAQ, business as usual.**
AI Summary
Quantum-Si Inc. filed an 8-K on February 5, 2024, to register its Class A common stock and redeemable warrants on the NASDAQ exchange. This filing ensures the company's securities are properly listed and traded, with warrants exercisable at $11.50 per share. For investors, this means the company is maintaining its public listing and providing clarity on its tradable securities, which is fundamental for liquidity and transparency.
Why It Matters
This filing confirms Quantum-Si's continued compliance with exchange listing requirements, which is crucial for maintaining investor confidence and the liquidity of its shares and warrants.
Risk Assessment
Risk Level: low — This 8-K is a routine compliance filing and does not indicate any new significant risks or changes to the company's operations.
Analyst Insight
Investors should view this as a routine compliance update, confirming the continued tradability of Quantum-Si's stock and warrants on NASDAQ. No immediate action is required based on this filing alone, but it reinforces the company's public market presence.
Key Numbers
- $11.50 — Warrant Exercise Price (The price at which each whole redeemable warrant can be exercised for one share of Class A Common Stock.)
Key Players & Entities
- Quantum-Si Inc. (company) — the registrant filing the 8-K
- NASDAQ (company) — the exchange where securities are registered
- $11.50 (dollar_amount) — the exercise price per share for redeemable warrants
- February 5, 2024 (date) — the date of the earliest event reported in the 8-K
Forward-Looking Statements
- Quantum-Si Inc. will continue to maintain its listing on the NASDAQ exchange. (Quantum-Si Inc.) — high confidence, target: 2025-02-05
FAQ
What is the purpose of Quantum-Si Inc.'s 8-K filing dated February 5, 2024?
The purpose of the 8-K filing is to report the registration of Quantum-Si Inc.'s Class A common stock and redeemable warrants on the NASDAQ exchange, as required by Section 12(b) of the Securities Exchange Act of 1934.
Which securities of Quantum-Si Inc. are registered pursuant to Section 12(b) of the Act, as stated in the filing?
The securities registered are 'Class A common stock, par value' and 'Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share'.
What is the exercise price for Quantum-Si Inc.'s redeemable warrants?
The exercise price for Quantum-Si Inc.'s redeemable warrants is $11.50 per share, as stated in the filing under the description of 'Redeemable Warrants'.
On which exchange are Quantum-Si Inc.'s securities registered?
Quantum-Si Inc.'s securities are registered on the NASDAQ exchange, as indicated by the 'Name of each exchange on which registered' column in the filing.
What was Quantum-Si Inc.'s former company name and when did the name change occur?
Quantum-Si Inc.'s former company name was HighCape Capital Acquisition Corp., and the date of the name change was 20200629 (June 29, 2020), as per the 'FORMER COMPANY' section of the filing.
Filing Stats: 596 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2024-02-05 08:09:48
Key Financial Figures
- $0.0001 — stered Class A common stock, par value $0.0001 per share QSI The Nasdaq Stock Mark
- $11.50 — mon stock, each at an exercise price of $11.50 per share QSIAW The Nasdaq Stock Ma
Filing Documents
- ef20020527_8k.htm (8-K) — 31KB
- ef20020527_ex99-1.htm (EX-99.1) — 16KB
- image00006.jpg (GRAPHIC) — 6KB
- 0001140361-24-005543.txt ( ) — 236KB
- qsi-20240205.xsd (EX-101.SCH) — 4KB
- qsi-20240205_def.xml (EX-101.DEF) — 18KB
- qsi-20240205_lab.xml (EX-101.LAB) — 27KB
- qsi-20240205_pre.xml (EX-101.PRE) — 20KB
- ef20020527_8k_htm.xml (XML) — 6KB
01
Item 7.01 Regulation FD Disclosure. On February 5, 2024, Quantum-Si Incorporated (the "Company") issued the press release furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference. The information in this Item 7.01 of this Current Report on Form 8-K and Exhibit 99.1 hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities under that Section. The information contained in this Item 7.01 and Exhibit 99.1 hereto shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
01
Item 8.01 Other Items. On February 5, 2024, the Company announced the launch of new platform enhancements for its Platinum protein sequencing instrument, with the release of its new V2 Sequencing Kits, expanding the Company's current Platinum application by incorporating peptide barcodes and accommodating new sample types.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release, dated February 5, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. QUANTUM-SI INCORPORATED By: /s/ Christian LaPointe, Ph.D. Name: Christian LaPointe, Ph.D. Title: General Counsel Date: February 5, 2024